[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.92.239. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
September 27, 2010

Chocolate Intake, Depression, and Clinical Progression in HIV-HCV Coinfected Patients: Still More Questions Than Answers

Author Affiliations

Author Affiliations: INSERM, U912 (SE4S), Université Aix Marseille, IRD, UMR-S912, and ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France (Dr Carrieri and Mr Cohen); INSERM U897–ISPED, Bordeaux, France (Dr Winnock); and Institut Cochin, Université Paris–Descartes, INSERM U567-CNRS (UMR 8104), Paris, France (Dr Salmon).

Arch Intern Med. 2010;170(17):1607. doi:10.1001/archinternmed.2010.330

Rose and colleagues1 reported intriguing results showing that elevated chocolate intake was found in individuals with probable major depression (as defined by a Center for Epidemiologic Studies Depression Scale [CES-D] score of ≥22), whatever the sex of the individual.

Although one review has already concluded that there is no evidence that chocolate has a significant impact on depression,2 the interrelationship among elevated chocolate intake, depression, and clinical progression of human immunodeficiency virus (HIV) or hepatitis C virus (HCV) may be particularly fascinating in the HIV-HCV–positive population for several reasons. These individuals have a history of drug injection and/or alcohol abuse, which may both be detrimental to HIV treatment adherence and response.

First Page Preview View Large
First page PDF preview
First page PDF preview
×